A global market leader within the in vitro diagnostics industry, Randox Laboratories develops innovative diagnostic solutions for hospitals, clinical, research and molecular labs, food testing, forensic toxicology, veterinary labs and life sciences. With offices and distribution in over 145 countries, Randox offers customers improved efficiency, quality, cost-effectiveness and flexibility. Randox is committed to revolutionising healthcare on a global scale. With over 1300 employees globally, Randox is dedicated to meeting your testing needs.
Randox manufacture medical products which are used in 145 countries – worldwide.
We manufacture 4-5% of all diagnostic tests used in the world. These products are essential in the diagnosis of many diseases. People’s lives may depend on access to our products.
Our revolutionary Biochip Technology is helping diagnose Covid-19 and differentiating non-lethal infections with similar symptoms.
It is imperative that we continue to manufacture and send our products to patients globally.
So we need to instigate measures that reduce the chances of a shut-down or slow-down of our output.
We are carrying out an important health and ethical role in this Global Pandemic.
In that role we all understand the team-based nature of our work and that to get our job done we need to liaise across multiple disciplines.
We also need to access commercially sensitive information, which means that working from home is not possible.
Measures which we are instigating: